Bromberg J, Issa S, Bukanina K, et al. Effect of Rituximab in Primary Central Nervous System Lymphoma – results of the Randomized Phase III HOVON 105/ALLG NHL 24 Study. ASH 59th Annual Meeting & Exhibition, abstract 582.
Brentuximab vedotine plus chemotherapie voor CD30-positief perifeer T-cellymfoom
mrt 2019 | Lymfoom